These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3306712

  • 1. Human drug metabolism polymorphisms: use of recombinant DNA techniques.
    Nebert DW, Jaiswal AK.
    Pharmacol Ther; 1987; 33(1):11-7. PubMed ID: 3306712
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of individual human cytochromes P450 in drug metabolism and clinical response.
    Cholerton S, Daly AK, Idle JR.
    Trends Pharmacol Sci; 1992 Dec; 13(12):434-9. PubMed ID: 1293869
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K, Kittelmann M, Lütz S.
    Biotechnol Bioeng; 2010 Aug 01; 106(5):699-706. PubMed ID: 20506361
    [Abstract] [Full Text] [Related]

  • 5. Clinical importance of hepatic cytochrome P450 in drug metabolism.
    Spatzenegger M, Jaeger W.
    Drug Metab Rev; 1995 Aug 01; 27(3):397-417. PubMed ID: 8521748
    [No Abstract] [Full Text] [Related]

  • 6. [Heritable polymorphisms in oxidative drug metabolism].
    Kallio J.
    Duodecim; 1990 Aug 01; 106(5):408-14. PubMed ID: 1670108
    [No Abstract] [Full Text] [Related]

  • 7. Cytochrome P-450-dependent drug metabolism in skin.
    Ahmad N, Agarwal R, Mukhtar H.
    Clin Dermatol; 1996 Aug 01; 14(4):407-15. PubMed ID: 8862917
    [No Abstract] [Full Text] [Related]

  • 8. [50 years of cytochrome P450. Drug metabolism - from past to present].
    Saussele T.
    Med Monatsschr Pharm; 2014 Aug 01; 37(8):295-8. PubMed ID: 25158378
    [No Abstract] [Full Text] [Related]

  • 9. Molecular biological methods for characterizing drug-metabolizing enzymes in hepatic and extrahepatic tissues.
    Friedberg T.
    Skin Pharmacol Appl Skin Physiol; 1998 Aug 01; 11(2):61-9. PubMed ID: 9603656
    [Abstract] [Full Text] [Related]

  • 10. Interactions of drug metabolites with hepatic cytochrome P-450. Some implications for drug metabolism.
    Bast A.
    Pharm Weekbl Sci; 1982 Aug 20; 4(4):113-4. PubMed ID: 7133961
    [No Abstract] [Full Text] [Related]

  • 11. [Genetic control of maturation of drug metabolism].
    Cresteil T.
    Arch Pediatr; 2001 May 20; 8 Suppl 2():347s-349s. PubMed ID: 11394112
    [No Abstract] [Full Text] [Related]

  • 12. Atypical kinetic profiles in drug metabolism reactions.
    Hutzler JM, Tracy TS.
    Drug Metab Dispos; 2002 Apr 20; 30(4):355-62. PubMed ID: 11901086
    [No Abstract] [Full Text] [Related]

  • 13. Use of in vitro human metabolism studies in drug development. An industrial perspective.
    Rodrigues AD.
    Biochem Pharmacol; 1994 Dec 16; 48(12):2147-56. PubMed ID: 7811296
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism.
    Isvoran A, Louet M, Vladoiu DL, Craciun D, Loriot MA, Villoutreix BO, Miteva MA.
    Drug Discov Today; 2017 Feb 16; 22(2):366-376. PubMed ID: 27693711
    [Abstract] [Full Text] [Related]

  • 15. Role of human hepatic cytochromes P450 in drug metabolism and toxicity.
    George J, Farrell GC.
    Aust N Z J Med; 1991 Jun 16; 21(3):356-62. PubMed ID: 1953519
    [No Abstract] [Full Text] [Related]

  • 16. [The cytochrome P-450 system].
    Spigset O.
    Tidsskr Nor Laegeforen; 2001 Nov 20; 121(28):3296-8. PubMed ID: 11826461
    [No Abstract] [Full Text] [Related]

  • 17. Structural modelling of the human drug-metabolizing cytochromes P450.
    Lewis DF, Ito Y, Goldfarb PS.
    Curr Med Chem; 2006 Nov 20; 13(22):2645-52. PubMed ID: 17017916
    [Abstract] [Full Text] [Related]

  • 18. Chiral drug metabolism: a perspective.
    Kaye B.
    Biochem Soc Trans; 1991 Apr 20; 19(2):456-9. PubMed ID: 1889629
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of human cytochrome P450 enzymes.
    Guengerich FP.
    FASEB J; 1992 Jan 06; 6(2):745-8. PubMed ID: 1537465
    [Abstract] [Full Text] [Related]

  • 20. A malleable catalyst dominates the metabolism of drugs.
    Guengerich FP.
    Proc Natl Acad Sci U S A; 2006 Sep 12; 103(37):13565-6. PubMed ID: 16954196
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.